Page last updated: 2024-09-03

gefitinib and framycetin

gefitinib has been researched along with framycetin in 2 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(framycetin)
Trials
(framycetin)
Recent Studies (post-2010) (framycetin)
5,2315662,9198,151460653

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)framycetin (IC50)
30S ribosomal protein S6Escherichia coli K-120.032
30S ribosomal protein S7Escherichia coli K-120.032
50S ribosomal protein L15Escherichia coli K-120.032
50S ribosomal protein L10Escherichia coli K-120.032
50S ribosomal protein L11Escherichia coli K-120.032
50S ribosomal protein L7/L12Escherichia coli K-120.032
50S ribosomal protein L19Escherichia coli K-120.032
50S ribosomal protein L1Escherichia coli K-120.032
50S ribosomal protein L20Escherichia coli K-120.032
50S ribosomal protein L27Escherichia coli K-120.032
50S ribosomal protein L28Escherichia coli K-120.032
50S ribosomal protein L29Escherichia coli K-120.032
50S ribosomal protein L31Escherichia coli K-120.032
50S ribosomal protein L31 type BEscherichia coli K-120.032
50S ribosomal protein L32Escherichia coli K-120.032
50S ribosomal protein L33Escherichia coli K-120.032
50S ribosomal protein L34Escherichia coli K-120.032
50S ribosomal protein L35Escherichia coli K-120.032
50S ribosomal protein L36Escherichia coli K-120.032
30S ribosomal protein S10Escherichia coli K-120.032
30S ribosomal protein S11Escherichia coli K-120.032
30S ribosomal protein S12Escherichia coli K-120.032
30S ribosomal protein S13Escherichia coli K-120.032
30S ribosomal protein S16Escherichia coli K-120.032
30S ribosomal protein S18Escherichia coli K-120.032
30S ribosomal protein S19Escherichia coli K-120.032
30S ribosomal protein S20Escherichia coli K-120.032
30S ribosomal protein S2Escherichia coli K-120.032
30S ribosomal protein S3Escherichia coli K-120.032
30S ribosomal protein S4Escherichia coli K-120.032
30S ribosomal protein S5Escherichia coli K-120.032
30S ribosomal protein S8Escherichia coli K-120.032
30S ribosomal protein S9Escherichia coli K-120.032
50S ribosomal protein L13Escherichia coli K-120.032
50S ribosomal protein L14Escherichia coli K-120.032
50S ribosomal protein L16Escherichia coli K-120.032
50S ribosomal protein L23Escherichia coli K-120.032
30S ribosomal protein S15Escherichia coli K-120.032
50S ribosomal protein L17Escherichia coli K-120.032
50S ribosomal protein L21Escherichia coli K-120.032
50S ribosomal protein L30Escherichia coli K-120.032
50S ribosomal protein L6Escherichia coli K-120.032
30S ribosomal protein S14Escherichia coli K-120.032
30S ribosomal protein S17Escherichia coli K-120.032
30S ribosomal protein S1Escherichia coli K-120.032
50S ribosomal protein L18Escherichia coli K-120.032
50S ribosomal protein L2Escherichia coli K-120.032
50S ribosomal protein L3Escherichia coli K-120.032
50S ribosomal protein L24Escherichia coli K-120.032
50S ribosomal protein L4Escherichia coli K-120.032
50S ribosomal protein L22Escherichia coli K-120.032
50S ribosomal protein L5Escherichia coli K-120.032
30S ribosomal protein S21Escherichia coli K-120.032
50S ribosomal protein L25Escherichia coli K-120.032
50S ribosomal protein L36 2Escherichia coli K-120.032

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1

Other Studies

2 other study(ies) available for gefitinib and framycetin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010